Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-Huang Chen

Showing results (141-150 of 183) with videos related to

Pageof 19
Sort By:
The Oncologist|November 20, 2024
Real-world effectiveness and prognostic factors of durvalumab plus chemotherapy in a multicentric cohort with advanced biliary tract cancerWen-Kuan Huang, Yan-Jei Tang, Chiao-En Wu, et al.
Pathology Oncology Research : POR|October 18, 2016
Advances in Laparoscopic and Robotic Gastrectomy for Gastric CancerSheng-Han Tsai, Chien-An Liu, Kuo-Hung Huang, et al.
Oncotargets and Therapy|August 8, 2015
Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinomaChi-Tung Cheng, Yin-Yi Chu, Chun-Nan Yeh, et al.
Data in Brief|October 13, 2017
Dataset on the synthesis and characterization of boron fenbufen and its F-18 labeled homologChun-Nan Yeh, Chi-Wei Chang, Yi-Hsiu Chung, et al.
Cancer|July 20, 2012
Gene expression-based chemical genomics identifies heat-shock protein 90 inhibitors as potential therapeutic drugs in cholangiocarcinomaMing-Huang Chen, Kun-Ju Lin, Wu-Lung R Yang, et al.
Oncology|June 23, 2012
Evaluation of prognosis for carcinoma of unknown origin in elderly patientsHsueh-Ju Lu, Kuo-Wei Chen, Cheng-Hwai Tzeng, et al.
British Journal of Cancer|July 2, 2026
Efficacy and safety of a novel oral anti-vasculogenic mimicry agent, CVM-1118, in advanced well-differentiated neuroendocrine tumors: a Phase IIa trialChia-Jui Yen, Ming-Huang Chen, Yen-Yang Chen, et al.
Scientific Reports|December 20, 2016
KIF2A regulates the spindle assembly and the metaphase I-anaphase I transition in mouse oocyteMing-Huang Chen, Yu Liu, Ya-Long Wang, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 20, 2015
MART-10, the new brand of 1α,25(OH)2D3 analog, is a potent anti-angiogenic agent in vivo and in vitroKun-Chun Chiang, Chi-Chin Sun, Ming-Huang Chen, et al.
Biomedicines|August 27, 2021
Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the JAK2/STAT1/3/ALDH1A3 PathwayShin-Yi Chung, Yi-Ping Hung, Yi-Ru Pan, et al.
Pageof 19

Showing results (141-150 of 183) with videos related to

Sort By:
Pageof 19
The Oncologist|November 20, 2024
Real-world effectiveness and prognostic factors of durvalumab plus chemotherapy in a multicentric cohort with advanced biliary tract cancerWen-Kuan Huang, Yan-Jei Tang, Chiao-En Wu, et al.
Pathology Oncology Research : POR|October 18, 2016
Advances in Laparoscopic and Robotic Gastrectomy for Gastric CancerSheng-Han Tsai, Chien-An Liu, Kuo-Hung Huang, et al.
Oncotargets and Therapy|August 8, 2015
Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinomaChi-Tung Cheng, Yin-Yi Chu, Chun-Nan Yeh, et al.
Data in Brief|October 13, 2017
Dataset on the synthesis and characterization of boron fenbufen and its F-18 labeled homologChun-Nan Yeh, Chi-Wei Chang, Yi-Hsiu Chung, et al.
Cancer|July 20, 2012
Gene expression-based chemical genomics identifies heat-shock protein 90 inhibitors as potential therapeutic drugs in cholangiocarcinomaMing-Huang Chen, Kun-Ju Lin, Wu-Lung R Yang, et al.
Oncology|June 23, 2012
Evaluation of prognosis for carcinoma of unknown origin in elderly patientsHsueh-Ju Lu, Kuo-Wei Chen, Cheng-Hwai Tzeng, et al.
British Journal of Cancer|July 2, 2026
Efficacy and safety of a novel oral anti-vasculogenic mimicry agent, CVM-1118, in advanced well-differentiated neuroendocrine tumors: a Phase IIa trialChia-Jui Yen, Ming-Huang Chen, Yen-Yang Chen, et al.
Scientific Reports|December 20, 2016
KIF2A regulates the spindle assembly and the metaphase I-anaphase I transition in mouse oocyteMing-Huang Chen, Yu Liu, Ya-Long Wang, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 20, 2015
MART-10, the new brand of 1α,25(OH)2D3 analog, is a potent anti-angiogenic agent in vivo and in vitroKun-Chun Chiang, Chi-Chin Sun, Ming-Huang Chen, et al.
Biomedicines|August 27, 2021
Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the JAK2/STAT1/3/ALDH1A3 PathwayShin-Yi Chung, Yi-Ping Hung, Yi-Ru Pan, et al.
Pageof 19